Protein Sequencing Market Share

Protein Sequencing Market Overview:

The Protein Sequencing Market is anticipated to reach USD 1052.22 Million by 2030 at 3.40% CAGR during the forecast period 2022-2030. Protein sequencing technologies are used to determine and analyze the amino acid sequences of proteins or peptides. Increased focus on target-based medication development by biotechnology and pharmaceutical companies, as well as increased financial support for proteome research from the public and commercial sectors.

 Advancements in clinical mass spectrometry and analytical techniques are some of the factors that are expected to drive market growth during the forecast period. The National Cancer Institute Office of Cancer Clinical Proteomics Research, for example, offers funding options for proteomics research. However, the high cost of infrastructure and equipment may limit the expansion of the protein sequencing market over the assessment period.

Market Segmentation:

The protein sequencing market has been segmented into products and services, technology, application, and end user.

By products and services, the market has been segmented into reagent and consumables, instruments, analysis products/software, and protein sequencing services. The instrument segment has been further segmented into mass spectrometry instruments and Edman degradation sequencers. The reagents and consumables segment accounted for the largest share of the protein sequencing products market in 2017. The factors such as ongoing advancements in protein sequencing technologies and the rising number of sequencing procedures are expected to boost the growth of the segment.

On the basis of technology, the market has been segmented into mass spectrometry and Edman degradation.

On the basis of application, the market has been segmented into biotherapeutics, genetic engineering, and others. The biotherapeutics segment is anticipated to be the fastest growing segment during the forecast period.

The market, by end user, has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The protein sequencing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European protein sequencing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The protein sequencing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The protein sequencing market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global protein sequencing market owing to the rising application of protein sequencing in proteomic research, the development of protein sequencing, and availability of research funding in the region. For instance, in September 2016, the National Institute of Health (NIH) announced to fund for research on Proteomics, Immunoassay for TB Activation in HIV Patients.

Europe is expected to hold the second largest position in the global protein sequencing market. The market growth in this region is attributed to the increasing proteomics research and the availability of funding and infrastructure for research. For instance, PRIME-XS is a consortium of 12 European research institutes. It is a pan-European infrastructure for proteomics research.

The protein sequencing market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the increase in government funding for healthcare, rising R&D expenditure, and a growing number of biopharmaceutical companies.

The Middle East and Africa has the lowest share of the global protein sequencing market. Majority of the market of the region is anticipated to be held by the Middle Eastern region owing to the growing government initiatives for the healthcare sector.

Global Protein Sequencing Market Share (%), by Region, 2017

Source: White Papers, Company Presentations, Annual Reports

The Market of Protein Sequencing, by Products & Services

• Reagents and consumables


• Instruments




• Mass Spectrometry Instruments


• Edman Degradation Sequencers




• Analysis Products/Software


• Protein Sequencing Services

The Market of Protein Sequencing, by Technology

• Mass Spectrometry


• Edman Degradation

The Market of Protein Sequencing, by Application

• Biotherapeutics


• Genetic Engineering


• Others

The Market of Protein Sequencing, by End User

• 
  Pharmaceutical & Biotechnology Companies


• Academic Institutes & Research Centers


• Others

The Market of Protein Sequencing, by Region

• Americas




• North America




• US


• Canada




• South America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




•  Middle East & Africa




• Middle East


• Africa

The report for Protein Sequencing Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.Recent Development

BSI's objective is to make a positive influence in proteomic research, particularly by offering professionally supported software. Bioinformatics Solutions Inc. creates powerful algorithms based on cutting-edge research to solve basic bioinformatics difficulties. This small, agile team is dedicated to meeting the demands of pharmaceutical, biotechnological, and academic scientists, as well as advancing drug discovery research. The firm, started in 2000 in Waterloo, Canada, is comprised of a bright, award-winning, and clever crew of developers, scientists, and salespeople.

Charles River Laboratories International, Inc. offers drug discovery and development solutions such as research models and related services, as well as outsourced preclinical services. Segments the business is divided into two divisions: The firm produces and sells research models, mostly genetically and virally specified purpose-bred rats and mice, with roughly 150 distinct strains. It also offers a variety of complementary services to help clients support the usage of research models in medication development.

Intended Audience

• Protein sequencing Device Manufacturers and Distributors


• Mass Spectrometry Manufacturers and Distributors


• Pharmaceutical and Biotechnological Companies


• Contract Research Organizations


• Academic and Research Institutes


• Government Associations